LipoScience Inc. Reaches New 12-Month Low at $4.71 (LPDX)
LipoScience (NASDAQ:LPDX)’s share price reached a new 52-week low during trading hours on Monday, Analyst Ratings.Net reports. The company traded as low as $4.71 and last traded at $4.76, with a volume of 28,342 shares traded. The stock had previously closed at $4.94.
Several analysts have recently commented on the stock. Analysts at Barclays Capital cut their price target on shares of LipoScience (NASDAQ:LPDX) from $14.00 to $10.00 in a research note to investors on Wednesday, August 7th. They now have an “overweight” rating on the stock. Separately, analysts at UBS AG cut their price target on shares of LipoScience (NASDAQ:LPDX) from $15.00 to $7.00 in a research note to investors on Wednesday, August 7th. They now have a “buy” rating on the stock. Finally, analysts at Piper Jaffray Cos. downgraded shares of LipoScience (NASDAQ:LPDX) from an “overweight” rating to a “neutral” rating in a research note to investors on Friday, August 2nd. They now have a $6.00 price target on the stock, down previously from $14.00.
LipoScience has a 52-week low of $4.76 and a 52-week high of $11.84. The stock has a 50-day moving average of $5.13 and a 200-day moving average of $7.14. The company’s market cap is $72.0 million.
LipoScience, Inc, is a vitro diagnostic company. The Company’s first diagnostic test, the nuclear magnetic resonance (NASDAQ:LPDX) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.